Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. (Q30332934)

18 June 2017

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. (English)

1 reference

18 June 2017

1 reference

hepatocellular carcinoma

1 reference

12

Toyomasa Katagiri

1 reference

18 June 2017

Tetsuya Nakatsura

1

1 reference

18 June 2017

Yoshihiro Yoshitake

2

1 reference

18 June 2017

Satoru Senju

3

1 reference

18 June 2017

Mikio Monji

4

1 reference

18 June 2017

Hiroyuki Komori

5

1 reference

18 June 2017

Yutaka Motomura

6

1 reference

18 June 2017

Seiji Hosaka

7

1 reference

18 June 2017

Toru Beppu

8

1 reference

18 June 2017

Takatoshi Ishiko

9

1 reference

18 June 2017

Hidenobu Kamohara

10

1 reference

18 June 2017

Hiroshi Ashihara

11

1 reference

18 June 2017

Yoichi Furukawa

13

1 reference

18 June 2017

Shigetoshi Fujiyama

14

1 reference

18 June 2017

Michio Ogawa

15

1 reference

18 June 2017

Yusuke Nakamura

16

1 reference

18 June 2017

Yasuharu Nishimura

17

1 reference

18 June 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Biochemical and Biophysical Research Communications

18 June 2017

1 reference

18 June 2017

306

1 reference

18 June 2017

1

1 reference

18 June 2017

16-25

1 reference

18 June 2017

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

Genome-wide profiling of gene expression in 29 normal human tissues with a cDNA microarray.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

Gene cloning of immunogenic antigens overexpressed in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

Clinical and molecular aspects of the Simpson-Golabi-Behmel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

A new X-linked dysplasia gigantism syndrome: identical with the Simpson dysplasia syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

Report of another family with Simpson-Golabi-Behmel syndrome and a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

A new X-linked mental retardation-overgrowth syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

Further delineation of the Simpson-Golabi-Behmel (SGB) syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

Glypican-3 expression is silenced in human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

The implications of embryonic gene expression in neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900908-2

10.1016/S0006-291X(03)00908-2

7 January 2021

Identifiers

DOI

1 reference

18 June 2017

1 reference